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Available online 20 February 2018Background: Type D personality (high negative affectivity and social inhibition) is associated with cardiovascular
events and coronary plaque severity. Whether Type D is also related to functional vasomotion abnormalities is
unknown. We examined concurrent and predictive associations of Type D with endothelial dysfunction in
patients with coronary artery disease (CAD).
Methods: At baseline, 180 CAD patients (90% men; M= 58.0 years) completed Type D (DS14) and depression
scales, and entered a 12-week exercise program. Flow-mediated dilation (FMD) of the brachial artery and
circulating CD34+/KDR+/CD45+dim endothelial progenitor cells (EPCs) were assessed at baseline, 3 months,
and 12months. Logistic regression and linear mixed models were used to analyze endothelial function.
Results: TypeDpersonalitywas associatedwith decreased FMD across baseline, 3 months, and 12months (mixed
model analysis, p = 0.04), after adjustment for clinical characteristics, exercise training and depression. There
was no significant association between Type D and decreased EPCs (p = 0.07). Age and smoking were other
significant correlates of FMD and EPCs. Using a FMD b5.5% cut-off, Type D patients more often had endothelial
dysfunction at baseline (24/37 = 65%) than non-Type Ds (63/143 = 44%); OR = 3.03, 95% CI 1.04–8.80.
This significant Type D effect was confirmed in prospective analyses of endothelial dysfunction at 12 months
(OR= 3.43, 95% CI 1.01–11.64), and in subgroup analyses of male patients.
Conclusions: Type D personality was associated with impaired endothelial function in men with CAD. This asso-
ciationwas robust across time, independent fromdepressive symptoms, and supports the notion that Type D has
an adverse effect on cardiovascular health in patients with CAD.dical and Clini
etherlands.
nollet).







Despite major advances in treatment, patients with coronary artery
disease (CAD) continue to suffer cardiac events [1] that can also be
stress-related. Patients with Type D (distressed) personality are prone
to stress [2]; i.e., they tend to experience negative emotions (negative
affectivity) and inhibit self-expression (social inhibition). Type D is re-
lated to adverse events in cardiac patients [2], and the European Society
of Cardiology [3] and its cardiac rehabilitation section [4] have included
Type D as a psychosocial risk marker. Yet, some studies found no effect
of Type D on all-cause mortality [5]. A meta-analysis showed that Type
D predicted a 2-fold increased risk of cardiac events [6], but also indi-
cated heterogeneity among studies.cal Psychology,
access article underThis heterogeneity relates to the biological plausibility of Type D [7].
Re-analysis of studies on CAD showed that Type D predicted cardiac
events/death but not non-cardiac death [8]. Hence, Type D may be re-
lated to specific cardiovascular pathways [7]. Type D is related to in-
creased coronary plaque severity [9,10] but its role in functional
coronary abnormalities is unknown. Endothelial cells regulate vascular
and inflammatory responses, and endothelial dysfunction induces func-
tional coronary abnormalities that play a key role in the development of
CAD [11,12]. Flow-mediated dilation (FMD) is a measure of endothelial
function that reflects vasodilation through release of nitric oxide in re-
sponse to a hyperemia-induced increase in endothelial shear stress
[13,14]. FMD of the brachial artery is related to coronary endothelial
dysfunction [12], and has a strong prognostic value in predicting cardio-
vascular events [15].
Acute [16,17] and chronic [18,19] stress can lead to endothelial
dysfunction. Type D individuals [2] report more stress but it is unclear
whether Type D is directly related to endothelial function. Type D pre-
dicted poor FMD in patients with lung disease [20] while studies inthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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biomarkers of endothelial activation [23]. Type D might contribute
to endothelial dysfunction through different candidate pathways. In-
creases in superoxide anions formation [24], oxidative stress [25],
TNF-α [26], and cortisol [27] have been observed in Type D individuals,
and may induce endothelial dysfunction [1,12,13,28].
Therefore, our aimwas to examine the predictive value of Type D for
endothelial dysfunction in CAD. We also examined the link between
Type D and endothelial progenitor cells (EPC) as marker of endothelial
repair [13]. Because endothelial dysfunction [29,30] and the effect of
Type D on cardiovascular stress [31] may occur more in men than in
women, we also wanted to study Type D and endothelial dysfunction
among men in particular. Diabetes, hypertension, smoking and depres-
sion are associated with Type D [23,32–34] and were included as
covariates.
2. Methods
2.1. Study design and participants
Patients from the Study on Aerobic INTerval EXercise training in CAD (SAINTEX-CAD)
were included at the Antwerp University Hospital (n= 100) or Leuven University Hospi-
tal (n = 100) in Belgium. Rationale and methodology of this prospective trial are de-
scribed elsewhere [35]. In brief, 200 patients (90% men; m = 58.4 ± 9.1y) were
randomized to a supervised 12-week exercise program of aerobic interval or continuous
training. Inclusion criteria were: 1) angio-graphically documented CAD (stenosis ≥75%
in any branch) or acute myocardial infarction (AMI), 2) left ventricular ejection fraction
(LVEF) N40%, 3) on optimalmedical treatment, 4) stable regarding symptoms andmedica-
tion for at least 4 weeks, and 5) included between 4 and 12weeks following AMI, percu-
taneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) [35,36].
Patients underwent assessment of endothelial function by FMD and blood sampling
for quantification of EPCs at baseline, after 3 months, and after 12months. Blood sampling
was performed in the morning, in fasting conditions and patients refrained from exercise
at least 8 h before the measurements. Flow cytometric analyses were performed in the
Antwerp Laboratory of Cellular and Molecular Cardiology that served as the core labora-
tory [36]. The SAINTEX-CAD trial complied with the World Medical Association Declara-
tion of Helsinki on ethics in medical research. The study was approved by the local
ethics committees of both participating hospitals, and all participants gave written in-
formed consent [35].
2.2. Type D personality and depressive symptoms
Personality was assessed at baseline with the 14-item Type D Scale (DS14) [32]. The
DS14 comprises two 7-item measures; negative affectivity (NA) and social inhibition
(SI). Items are rated on a 5-point scale ranging from 0= false to 4= true. A cut-off ≥10
on the NA and SImeasures identifies individuals with elevated trait levels, and individuals
with a score ≥10 on both scales are categorized as TypeD [32–34]. TheNA and SI scales are
uni-dimensional and internally consistent (Cronbach'sα=0.88 and 0.86), and have good
test-retest reliability [32].
To compare the separate and combined effects of high and low trait levels, the cut-off
≥10 was used to define four distinct personality subgroups [33]; i.e., low on both traits
(NA ≤ 9 and SI ≤ 9; reference group), SI only (SI ≥ 10 but NA ≤ 9), NA only (NA ≥ 10 but
SI ≤ 9), and Type D (NA ≥ 10 and SI ≥ 10). Previously, we showed that this classification
schemewas successful in predicting prognosis in CAD patients, and that Type Dwas asso-
ciatedwith adverse cardiac eventswhile patients of the NA only or SI only subgroupswere
not at increased risk [8,33].
The Dutch 7-item depression measure [37] of the Hospital Anxiety and Depression
Scale was used to assess depressive symptoms and control for these symptoms in statisti-
cal analyses. The 7 items are rated on 4-point scale (0–3), and the total score ranges
between 0 and 21.
2.3. FMD assessment of endothelial function
Endothelial functionwas assessed by FMDof the brachial artery [36].Ultrasound scan-
ning was used to measure endothelium-dependent vasodilation in response to reactive
hyperemia [14]. To control environmental factors that could influence FMD assessment,
all analyses were performed in the morning, in fasting conditions and in a quiet
temperature-controlled room (21–24 °C) by a trained operator that was blinded for the
study intervention. Subjects refrained from exercise, food and caffeine at least 8 h before
the measurements. Patients were in supine position and the brachial artery was imaged
above the antecubital fossa. Blood pressure was obtained after 10 min of rest with an au-
tomated blood pressure monitor (Omron M6). The forearm was occluded during 5 min
with a cuff placed on the forearm distal to the brachial artery, at a cut-off pressure of at
least 200 mmHg or 60 mmHg supra-systolic. Images were continuously recorded from
1 min before cuff inflation to 3 min after cuff deflation and were analyzed using edge-
detection software FMD-i by Flomedi (Brussels, Belgium). FMDwas expressed as the per-
centage change in diameter of the brachial artery [14]. Measurements were performed bytwo experienced investigators and analyses of the measurements were blinded to the
treatment allocation and study visits.
2.4. Clinically relevant endothelial dysfunction
In addition to analyzing continuous FMD values, we also examined impairment in en-
dothelial function in both concurrent (baseline) and prospective (12 months) analyses.
There is a wide variability in FMD levels across studies [38], and a lack of consensus for a
clinical relevant cut-off value [14]. In a study of patients with CAD, impaired FMD as de-
fined by a cut-off b5.5% predicted an increased risk of adverse cardiovascular events
[39]. In our study, themedian value of FMDwas 5.6% and 6.1% at baseline and 12months.
This corresponds well to themedian of 5.2% reported in a meta-analysis of 16 studies [38]
and to the cut-off b5.5% that has been related to poor prognosis in CAD [39]. Therefore, we
used the FMD b5.5% cut-off to define clinically relevant endothelial dysfunction both at
baseline and 12months follow-up.
2.5. Assessment of circulating EPCs
Circulating EPC numbers, defined as CD34+/KDR+/CD45+dim cells, were quantified by
multi-parametric flow cytometry [36]. Whole blood was fixed (TransFix, Caltag
Medsystems, Buckingham, UK) and processed 2 to 3 days after sampling. After pretreat-
ment with Fc receptor blocking reagent (Miltenyi Biotec, Bergisch Gladbach, Germany),
samples were incubated with CD34-PE-Cy7 (BD Pharmingen, Erembodegem, Belgium),
KDR-APC (R&D Systems, Minnesota), and CD45-APC-H7 (BD Pharmingen) antibodies. Ad-
dition of the nucleic acid dye SYTO 13 (Life Technologies, Ghent, Belgium) allowed identifi-
cation of non-nucleated cells and cellular debris. At least one million total events were
recorded on a FACSCanto II flow cytometer (Becton Dickinson, New Jersey). Fluorescence-
minus-one samples and unstained samples served as negative controls. Numbers of EPCs
were analyzed using FACSDiva software (Becton Dickinson, version 6.1.2) and expressed
as cells per million CD45+ mononuclear cells with low forward (FSC) and side scatter
(SSC) [36].
2.6. Statistical analyses
One-way analyses of variance and chi-square tests were used to examine differences
in continuous and categorical baseline variables as a function of personality. Two separate
linear mixed models were used to assess the association of the different personality pro-
files with FMD and EPC markers of endothelial function across 3 time points (baseline,
3 months, 12months). In the linear mixed model analyses, all three time points were in-
cluded andmodeled according to an unstructured covariancematrix. Demographics (age,
sex), exercise treatment (interval or continuous training), standard cardiovascular risk
factors (hypertension, diabetes, smoking), and depressive symptomswere included as co-
variates in these analyses. Next, we used multiple logistic regression models to assess the
concurrent (baseline) and prospective (12 months) relationships between personality
profiles and endothelial dysfunction as defined by the FMD cut-off b5.5% [39]. These
models included the covariates mentioned above. Logistic regression models of endothe-
lial dysfunctionwere replicated in the group ofmenwith CAD. All statistical analyseswere
performed using SPSS 24.0 for Mac and SPSS 22.0 for Windows (IBM SPSS Statistics for




For 12 of the 200 participants, personality assessment was missing;
Table 1 presents the characteristics of the 188 patients included in this
study. The mean age was 58.0 years, 90% were men, 60% had survived
an AMI, and the large majority of patients underwent PCI or CABG.
Based on the standard cut-off ≥10 on the NA and SI measures of the
DS14 [32], 39 patients (21%) were classified as Type D personality, 29
(15%) as NA only, 37 (20%) as SI only, and 83 (44%) as the reference
groupwith low scores on both traits. Type D personality was not signif-
icantly related to age, sex, diagnosis of an index AMI, invasive treatment
with CABG or PCI, hypertension, diabetes, smoking or medication use
(statins, acetylsalicylic acids, beta-blockers, angiotensin-converting en-
zyme inhibitors, anti-diabetic medication, diuretics, nitrates). However,
patients with Type D personality displayed significantly higher levels of
depressive symptoms than non-Type D patients did (Table 1).
3.2. FMD and EPC measures of endothelial function
Mean scores (±standard deviation) of FMD were 5.61 ± 2.83,
6.68 ± 2.97 and 6.29 ± 3.22 at baseline, 3 months and 12 months.
FMDwasmissing for 8, 30, and45 patients at these 3 timepoints.Median
Table 1









Age (years; mean ± SD) 58.0 ± 9.1 58.2 ± 9.2 57.6 ± 9.2 0.73
Male sex 170 (90%) 136 (91%) 34 (87%) 0.44
AMI 113 (60%) 93 (62%) 20 (51%) 0.21
PCI 125 (67%) 99 (66%) 26 (67%) 0.98
CABG 57 (30%) 44 (30%) 13 (33%) 0.65
Duration CAD N 3 months 42 (22%) 33 (22%) 9 (23%) 0.90
Peak VO2 (ml/kg/min) 22.7 ± 5.7 22.9 ± 5.7 22.4 ± 5.8 0.49
Hypertension 98 (52%) 75 (50%) 23 (59%) 0.34
Diabetes 34 (18%) 27 (18%) 7 (18%) 0.98
Smoking 23 (12%) 15 (10%) 8 (21%) 0.20
Depressive symptoms 3.5 ± 3.3 2.6 ± 2.7 6.9 ± 3.3 0.0001
Medication
Statins 184 (98%) 146 (98%) 38 (97%) 0.83
Acetylsalicylic acids 176 (94%) 140 (94%) 36 (92%) 0.71
Beta-blockers 158 (84%) 128 (86%) 30 (77%) 0.17
ACE-inhibitors 130 (69%) 107 (72%) 23 (59%) 0.12
Oral antidiabetic 27 (14%) 19 (13%) 8 (21%) 0.22
Insulin 9 (5%) 8 (5%) 1 (3%) 0.47
Diuretics 15 (8%) 10 (7%) 5 (13%) 0.21
Nitrates 8 (4%) 6 (4%) 2 (5%) 0.76
Type D personality defined by the combination of a negative affectivity score ≥10 and a
social inhibition score ≥10 on the DS14 [32]; all other patients classified as non-Type D.
Data are expressed as means ± standard deviation (SD) for continuous variables or as
number and percentages for dichotomous variables.
ACE = angiotensin-converting enzyme; AMI = acute myocardial infarction; CABG =
coronary artery bypass grafting; CAD = coronary artery disease; PCI = percutaneous
coronary intervention; Peak VO2= peak oxygen uptake.
Table 2
Mean FMD and EPC levels, and mixed model analyses of FMD and EPC levels across base-















FMD baseline 6.2 (2.9) 5.4 (2.5) 5.3 (2.4) 4.9 (3.0)
FMD 3 months 6.9 (3.0) 7.6 (3.5) 6.0 (2.4) 6.1 (2.9)
FMD 12 months 6.3 (2.8) 6.7 (4.6) 6.9 (3.0) 5.3 (2.9)
EPC baseline 12.4 (9.0) 11.6 (8.6) 12.3 (12.0) 9.0 (6.5)
EPC 3 months 12.3 (15.0) 9.2 (7.3) 13.3 (9.3) 11.5 (7.7)
EPC 12 months 11.4 (9.9) 9.7 (10.3) 11.1 (9.4) 10.5 (9.4)
β t p 95% CI
(2b) FMD mixed model
Age (years) −0.07 −3.57 0.001 [−0.11, −0.03]
Male sex 0.52 0.82 0.41 [−0.74, 1.78]
Hypertension 0.32 0.89 0.38 [−0.39, 1.02]
Diabetes −0.29 −0.66 0.51 [−1.18, 0.59]
Smoking 0.14 0.25 0.80 [−0.96, 1.24]
Training program 0.12 0.34 0.73 [−0.56, 0.80]
Depressive symptoms −0.01 −0.18 0.86 [−0.15, 0.12]
Negative affectivity only −0.27 −0.48 0.64 [−1.41, 0.86]
Social inhibition only −0.62 −1.36 0.18 [−1.53, 0.28]
Type D personality −1.14 −2.00 0.047 [−2.27, −0.02]
(2c) EPC mixed model
Age (years) −0.05 −0.91 0.37 [−0.16, 0.06]
Male sex −3.25 −1.76 0.08 [−6.90, 0.39]
Hypertension 0.51 0.51 0.61 [−1.49, 2.51]
Diabetes −1.66 −1.32 0.19 [−4.15, 0.82]
Smoking −3.35 −2.08 0.039 [−0.29, −0.01]
Training program −0.71 −0.73 0.47 [−2.65, 1.22]
Depressive symptoms 0.29 1.40 0.16 [−0.12, 0.71]
Negative affectivity only −2.63 −1.59 0.11 [−5.90, 0.63]
Social inhibition only −0.26 −0.20 0.84 [−2.80, 2.29]
Type D personality −3.03 −1.81 0.07 [−6.33, 0.27]
SD = standard deviation; FMD was missing for 8, 30 and 45 patients, and EPC for 23,
33 and 43 patients at these 3 time points, respectively. Personality subgroups
defined by the cut-off ≥10 on the negative affectivity (NA) and social inhibition (SI) traits
of the DS14 [32,33]. Negative affectivity only=NA ≥ 10 but SI ≤ 9, Social inhibition only=
SI ≥ 10 but NA ≤ 9, Type D personality=NA ≥ 10 and SI ≥ 10, patients scoring low on both
traits (NA ≤ 9 and SI ≤ 9) were used as a reference group to estimate the effects of the NA
only, SI only, and Type D personality profiles.
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line, 3 months and 12 months; EPC levels were missing for 23, 33 and
43 patients, respectively. Index AMI, PCI, CABG, andmedication (statins,
aspirin, beta-blockers, diuretics, nitrates, angiotensin-converting en-
zyme inhibitors, diabetic medication) were not associated with FMD or
EPCs at baseline or follow-up, andwere not included in further statistical
analyses.
3.3. Personality differences in endothelial function
Table 2a presents the mean FMD and EPC levels at three time points
(baseline, 3 months, 12months), stratifiedby the4 different personality
profiles. Mixedmodel analysis showed that Type D personality was sig-
nificantly associatedwith decreased FMD across these time points, after
adjustment for age, sex, hypertension, diabetes, smoking, training pro-
gram, and depressive symptoms (Table 2b). In contrast, the NA only
or SI only personality profiles were not significantly related to FMD. In-
creasing age was also independently associated with decreased FMD
levels, but depressive symptoms were not associated with FMD.
Smoking was the only significant covariate of decreased EPC
levels across the baseline, 3 months and 12 months assessments
(Table 2c). Type D (p = 0.07), NA only, SI only, and depression were
not significantly associated with EPCs across time. In further concurrent
and prospective analyses, we examined the extent to which personality
profiles were related to clinically significant endothelial dysfunction as
indicated by a cut-off b5.5% on FMD [39].
3.4. Personality and endothelial dysfunction
The median FMD at baseline was 5.6%. Using a cut-off b5.5% on FMD
[39], 48% of thepatients had endothelial dysfunction at baseline and 38%
patients at 12 months follow-up. At baseline, 42% (11/26) of patients
with NA only had endothelial dysfunction, 54% (20/37) of those with
SI only, and 40% (32/80) of those with low levels on both traits; these
frequencies of endothelial dysfunction were not significantly different.
In contrast, Type D patients had a higher frequency of endothelialdysfunction (24/37 = 65%; OR = 3.03, p = 0.042), after adjustment
for age, sex, exercise, and depression (Table 3a). Hypertension, diabetes
and smoking were unrelated to FMD (Table 2b) and were not included
in further analyses. Prospective analyses confirmed that Type D person-
ality (OR= 3.43, p = 0.048), but not NA or SI only, was independently
associated with endothelial dysfunction at 12months (Table 3b).
Subgroup analysis in men with CAD (n = 164; 91% of patients)
yielded similar findings; i.e., Type D was associated with endothelial
dysfunction at baseline (OR= 4.75, p = 0.01), while the NA only or SI
only subgroups were not at increased risk (Table 3c). We could not
show an association between Type D and endothelial function in
women (n = 16; 9% of CAD patients). The prospective findings on
Type D and increased risk of endothelial dysfunction were also repli-
cated in the subgroup analysis of male patients with CAD (Table 3d;
OR= 4.25, p = 0.03).
3.5. Type D versus non-Type D dichotomy in men with CAD
In a final subgroup analysis of men with CAD, we pooled 3 profiles
(NA only, SI only, and reference with low levels of both traits) in one
composite non-Type D personality profile. This dichotomous approach
[33] yielded a clear association of Type Dwith a higher frequency of en-
dothelial dysfunction both at baseline (Fig. 1a) and 12months follow-
up (Fig. 1b). Logistic regression analysis confirmed that increasing age
(OR = 1.05, 95% CI 1.02–1.09) and the Type D dichotomy (Type D vs
non-Type D; OR= 3.72, 95% CI 1.32–10.53), but not training program
(p = 0.35) or depression (p = 0.65), were independent correlates of
Table 3
Logistic regression models of endothelial dysfunction at baseline and 12 months in the
total group, and in the subgroup of men with CAD.a
(3a) Total group -
baseline
(3b) Total group -
12 months
OR 95% CI p OR 95% CI p
Age (years) 1.06 [1.02–1.10] 0.001 1.02 [0.98–1.06] 0.33
Male sex 1.07 [0.35–3.28] 0.91 2.14 [0.47–9.77] 0.32
Training program 0.71 [0.38–1.33] 0.29 1.03 [0.52–2.07] 0.93
Depressive symptoms 1.01 [0.89–1.15] 0.85 0.93 [0.81–1.08] 0.37
Negative affectivity only 1.28 [0.45–3.67] 0.64 1.56 [0.49–4.95] 0.45
Social inhibition only 1.92 [0.85–4.33] 0.12 0.67 [0.26–1.71] 0.40
Type D personality 3.03 [1.04–8.80] 0.042 3.43 [1.01–11.64] 0.048
(3c) Male patients -
baseline
(3d) Male patients –
12 months
OR 95% CI p OR 95% CI p
Age (years) 1.06 [1.02–1.10] 0.005 1.01 [0.97–1.05] 0.60
Training program 0.72 [0.37–1.40] 0.34 1.18 [0.58–2.42] 0.65
Depressive symptoms 0.97 [0.85–1.11] 0.66 0.92 [0.79–1.07] 0.26
Negative affectivity only 1.26 [0.41–3.88] 0.69 1.63 [0.49–5.36] 0.42
Social inhibition only 2.01 [0.87–4.62] 0.10 0.69 [0.27–1.79] 0.45
Type D personality 4.75 [1.45–15.57] 0.01 4.25 [1.15–15.75] 0.03
Type D=NA ≥ 10 and SI ≥ 10, Negative affectivity only =NA ≥ 10 but SI ≤ 9, Social inhibi-
tion only= SI ≥ 10 but NA ≤ 9. Patients scoring low on both traits (NA ≤ 9 and SI ≤ 9)were
used as a reference group to estimate the effects of the Type D,NA only and SI only person-
ality profiles.
CI = confidence interval; OR= odds ratio.
a Endothelial dysfunction was defined by a FMD cut-off b5.50 [39] at baseline and at
12months, respectively. Personality subgroups were defined by the standard cut-off ≥10
on the negative affectivity (NA) and social inhibition (SI) traits of the DS14 [32,33].
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analysis, the Type D dichotomy was the only predictor of endothelial
dysfunction at 12 months (OR= 3.59, 95% CI 1.15–11.16).
4. Discussion
In patients with CAD who have a Type D personality profile, endo-
thelial function was impaired across baseline, 3 months and 12months
assessment, as compared to non-Type D patients. This adverse Type D
effect remained significant after adjustment for clinical characteristics,
exercise training and depressive symptoms. Type D was related to
endothelial dysfunction as defined by a FMD cut-off b5.5% [39] in con-
current analyses, and was prospectively associated with endothelialFig. 1. Percentage of male patients with endothelial dysfunction at baseline (1a) and at 12mont
off b5.5% [39]. Percentages of patients with endothelial dysfunction are presentedwithin each b
inhibition traits of the DS14 [32,33]; all other personality profiles classified as non-Type D.dysfunction at 12 months follow-up. The association of Type D with
EPCs was not significant (p = 0.07), and depressive symptoms were
not related to FMD or EPCs.
Older age [30] was also related to a decreased FMD levels across the
3 time points. Hypertension, diabetes, and smoking can interfere with
the endothelial response [13], but these covariates were not related to
continuous FMD levels in our study. The link between Type D and endo-
thelial function was not influenced by type of exercise training [13]. En-
dothelial function improved in the SAINTEX-CAD trial [35] but this
improvement was not accompanied by altered levels of EPCs, and
FMDwas not related to EPC levels at baseline or 3 months [36]. Low cir-
culating EPCs levels predict increased mortality in patients with CAD
[40]. Type D has been related to low EPC levels in patients with heart
failure [41] but this link between Type D and decreased EPCs was not
statistically significant in the current study (β=−3.03, p = 0.07).
This is the first study to report on Type D and endothelial dysfunc-
tion in CAD. None of the patients participated in other Type D studies,
allowing for replication of findings on the role of Type D in CAD. Previ-
ously, others showed that Type D was related to increased coronary
plaque severity [9,10]. Our study suggests that Type D is also involved
in functional vasomotion abnormalities that further increase cardiovas-
cular risk in CAD patients [11]. Brachial FMD is closely related to coro-
nary endothelial function and predicts cardiac events [15]. Our median
FMD value of 5.6% corresponds to the median of 5.2% in the literature
[38] and to the cut-off b5.5% that predicts poor prognosis in patients
with CAD [39]. Using this cut-off in concurrent and prospective models,
Type D patients, who are high in both NA and SI, were at increased risk
of endothelial dysfunction. Patients with NA or SI only were not at risk,
suggesting that it is the combination of both traits that drives the effect
of Type D on endothelial dysfunction.
Evidence suggests that chronic stress and repeated exposure to tran-
sient stress may lead to endothelial dysfunction [16–19,42–44]. Mental
stress causes transient [16] and prolonged [42] endothelial dysfunction,
which was also confirmed in meta-analysis [17]. The chronic burden of
caregiving [18], posttraumatic [19] and social [43] stress, and sup-
pressed anger [44] have all been related to endothelial dysfunction.
Hence, the vulnerability of Type D individuals to chronic distress [2],
posttraumatic [45] and social [46] stress, and suppressed anger [47]
supports the psychological plausibility of the link between Type D and
impaired endothelial function.
Increases in superoxide anions formation, oxidative stress, TNF-α,
and cortisol are biological pathways by which Type D can contribute
to endothelial dysfunction [1,12,28]. Previous studies showed increasedhs follow-up (1b), stratified by Type D personality.(a) (a)Endothelial dysfunction: FMD cut-
ar. Type D personality defined by the cut-off ≥10 on both the negative affectivity and social
209J. Denollet et al. / International Journal of Cardiology 259 (2018) 205–210macrophage activity and superoxide anion production [24], higher
levels of oxidative stress [25], and a pro-inflammatory cytokine profile
with higher TNF-α levels [26] in cardiac patients with Type D than in
non-Type D patients. Type D is also related to increased cortisol and
hypothalamic-pituitary-adrenal axis function after an acute cardiac
event [27] and in response to acute stress [46]. Endothelial-leukocyte
adhesion molecule-1 (E-Selectin) is an important adhesion molecule
for endothelial cell activation that promotes atherosclerosis [13]. In
the Maastricht Study, Type D was related to biomarkers of endothelial
activation, including E-Selectin [23]. Overall, thesefindings on biological
pathways support the role of endothelial dysfunction as a possible
mechanism that connects Type D to increased cardiovascular risk.
There are also behavioral pathways by which Type D can promote
endothelial dysfunction, including increased vulnerability to depression
[2,23]. Depressive symptoms have been related to decreased FMD in
some studies [48]. This was not the case in our study of cardiac patients,
and there are other studies that found no link between depressive
symptoms and FMD [18,44]. Yet, our findings are consistent with the
notion that Type D and depression are different forms of distress, and
may have incremental prognostic value in patients with CAD [49].
FMD has been used to compare endothelial function in age, sex and
disease subgroups [14]. Personality is another individual difference var-
iable that can explain heterogeneity in endothelial function. In general
populations, Type D was not related to FMD in one study [22], but was
related to endothelial dysfunction as measured by FMD of the brachial
artery [21] and anendothelial biomarker sum-score [23] in 2 other stud-
ies. Our study extends this previous research by studying patients with
CAD, and looking at this association across 3 time points. There are also
sex differences in CAD [29] and endothelial function [29,30]. Men have
worse endothelial function than women until about age 70 [29], and
Type D is related to a sensitized cardiovascular stress-response in men
but not women [31]. Our sex-subgroup analyses yielded a clear associ-
ation between Type D and endothelial dysfunction in men with CAD.
We could not show this association between Type D and endothelial
function in women, which is due to the very small number of women
(n= 16) included in the current study.
Limitations of this study include the lower participation and higher
drop-out rates in women compared to men [35], and the relatively
high number of missing values of FMD at follow-up. There is a lack of
consensus for a clinical cut-off value on FMD and the definition of
EPCs remains a matter of debate. Our findings provide no direct evi-
dence of a causal relationship between Type D and risk of CAD. How-
ever, they are consistent with the notion that endothelial dysfunction
is a candidate pathway that should be studied in future Type D research.
Finally, Type D was not significantly related to number of EPCs.
Strengths of our study include the standard assessment of four distinct
personality subtypes, and the repeated assessment of FMD to study
the robustness of the Type D effect across time. Most previous studies
on psychological factors and FMD report on cross-sectional or retro-
spective analyses [48], and the literaturewould be strengthened by pro-
spective studies such as ours.
Coronary arteries represent a functional conduit system [11]. Others
showed that Type Dwas associated with structural coronary abnormal-
ities [9,10]. Our study suggests that another possible mechanistic basis
for the link between Type D and coronary events resides at the level of
endothelial dysfunction. Together with findings from clinical research
linking Type D with a higher risk of cardiac events in coronary patients
[8,33], it is becoming apparent that the adverse effect of Type D might
involve cardiovascular pathways that contribute to CAD.
In conclusion, endothelial dysfunction [38,39] emerges as a key fac-
tor that may link Type D to a higher risk of cardiac events in male pa-
tients with CAD [8]. Research needs to confirm that disease-specific
pathways contribute to poor prognosis in patients with CAD and
TypeD. Yet, ourfindings suggest that the combination of plaque severity
and endothelial dysfunction in the coronary arteries render Type D
patients at increased risk, and support the notion that perceivedstress during social interaction has a direct influence on cardiovascular
health [43].
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